Global Cell Solutions (GCS) has received a National Science Foundation (NSF) Small Business Innovation Research (SBIR) grant to study the immobilization of growth factors on the GCS GEM substrate. The NSF SBIR program supports the development of new technologies through funding provided to high-quality opportunities that could lead to significant commercial and public benefit.

 "The National Science Foundation's support will give GCS the opportunity to develop a new method of cell culture in which the signaling proteins usually found in solution are now immobilized to the cell culture surface." said Brad Justice, the Principal Investigator of the awarded grant and Vice President of Research at GCS. "The products we are developing will enable drug discovery organizations to simplify the culture process, lowering costs and reducing the use of animal derived media components. Future work is aimed at tethering signaling proteins involved in the maintenance and differentiation of stem cells with hopes of advancing stem cell based drug discovery and therapeutics."

GCS received this grant under the NSF SBIR/STTR Solicitation (NSF 09-609) and the award abstract can be viewed here. 

About Global Cell Solutions 

Global Cell Solutions, Inc., provides a unique approach to cell culture which will enable the next generation of scientific breakthroughs in medicine, therapeutics, and biotechnology and pharmaceuticals research. The company's products and services, centered on its proprietary GEM^TM substrate and BioLevitator^TM, are focused on delivering an innovative solution that provides life sciences with new cell culture tools and solutions leading to drug discovery and human therapies as well as predictive biomanufacturing processes. For more information, visit www.globalcellsolutions.com.